You are in the accessibility menu

Please use this identifier to cite or link to this item: http://acervodigital.unesp.br/handle/11449/133761
Title: 
Anti-inflammatory drug design by molecular hybridization approach
Author(s): 
Institution: 
Universidade Estadual Paulista (UNESP)
ISSN: 
1424-8247
Sponsorship: 
  • Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP)
  • Conselho Nacional de Pesquisa (CNPq)
Sponsorship Process Number: 
  • FAPESP: 2010/12495-6
  • FAPESP: 2010/50330-9
  • CNPq: 308157/2010-9
Abstract: 
The design of new drugs with better physiochemical properties, adequateabsorption, distribution, metabolism, and excretion, effective pharmacologic potency andlacking toxicity remains is a challenge. Inflammation is the initial trigger of severaldifferent diseases, such as Alzheimer s disease, asthma, atherosclerosis, colitis, rheumatoidarthritis, depression, cancer; and disorders such as obesity and sexual dysfunction.Although inflammation is not the direct cause of these disorders, inflammatory processesoften increase related pain and suffering. New anti-inflammatory drugs developed usingmolecular hybridization techniques to obtain multiple-ligand drugs can act at one or multipletargets, allowing for synergic action and minimizing toxicity. This work is a review of newanti-inflammatory drugs developed using the molecular modification approach.
Issue Date: 
2011
Citation: 
Pharmaceuticals, v. 4, p. 1450-1474, 2011.
Time Duration: 
1450-1474
Keywords: 
  • Anti-inflammatory
  • Hybridization
  • Multiple-ligands
  • Mutual prodrug
Source: 
http://dx.doi.org/10.3390/ph4111450
URI: 
Access Rights: 
Acesso aberto
Type: 
outro
Source:
http://repositorio.unesp.br/handle/11449/133761
Appears in Collections:Artigos, TCCs, Teses e Dissertações da Unesp

There are no files associated with this item.
 

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.